Alert: Cineplex Inc. (TSX:CGX) Is a Buy-Low Target in April

Cineplex Inc. (TSX:CGX) will suffer in Q1 due to soft box office numbers but big help is one the way. The stock is a nice buy-low target right now.

| More on:
Business man on stock market financial trade indicator background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Cineplex (TSX:CGX) has been a frustrating stock to own over the past two years. Before 2018, concluded I’d discussed whether the stock was worth betting on ahead of the New Year. Cinemas had raked in record revenues in 2018, but the momentum at Cineplex came to a screeching halt after the release of its 2018 third-quarter report.

The stock suffered another sharp drop after the release of its fourth-quarter and full-year results on February 15. Total revenues rose a paltry 0.4% year-over-year in Q4 2018, and theatre attendance dropped 3.2% to 17 million. For the full year, revenues climbed 3.8% to $1.61 billion, while attendance still fell 1.6% to 69.3 million.

Cineplex CEO Ellis Jacob has expressed confidence in Cineplex overcoming its many challenges going forward. He was quick to call out the “blip” that was the disappointing 2017 summer box office and questioned the overreaction to the Q3 2018 report. Cineplex has worked hard to diversify its business, but still relies heavily on box office performance.

Shares of Cineplex have dropped 5% month-over-month as of close on April 2. The stock is down 3.2% in 2019 so far. The North American box office had a rough start to 2019, as revenue for the first eight weeks of the year hit an eight-year low. Back in February I’d pointed out why this was reason for concern.

There was some hope that Captain Marvel would provide a much-needed boost in the month of March. The film has exceeded $355 million in its domestic gross and will surpass the $1 billion mark worldwide, but this will not be enough to bolster a very weak Q1 2019. According to box office mojo, the quarter-to-date North American box office is down 21% from the prior year.

Cineplex is expected to release its first-quarter results in early May. Investors should expect a negative report, but I believe the stock is a solid buy-low candidate in the early spring.

The 2019 release schedule should still inspire confidence for the cinema industry. Avengers: Endgame, the sequel to Avengers: Infinity War, saw its tickets go on pre-sale this week. It took six hours for the film to break the previous single-day sales record on the movie ticket site Fandango, which was held by Stars Wars: The Force Awakens. Pre-sale response on other websites has been equally impressive.

Avengers: Infinity War pulled in over $2 billion worldwide by the end of its run. The hype surrounding Avengers: Endgame suggests that we are be about to witness some history this year. Expect the film to easily break the $2 billion worldwide mark, as well as the $700 million domestic mark. This, in my view, is a conservative outlook.

This is not the only film that will give a boost to cinema revenues. Other future blockbusters include Toy Story 4, Aladdin, The Lion King, and Frozen 2. The final installment in the third Star Wars trilogy will be released in December.

Box office hype aside, Cineplex stock is trading at the low end of its 52-week range. The stock had an RSI of 46 as of close on April 2, which puts it in neutral territory. Cineplex stock offers a monthly dividend of $0.145 per share, which represents a highly attractive 7% yield. Income and value investors should be targeting Cineplex today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Investing

Investing

Pitch Braze Ad

This is my excerpt.

Read more »

Investing

KM Throwaway Post

Before Fool Braze Ad Mid-Article-Pitch The sun dipped low on the horizon, casting long, golden shadows across the quiet park.…

Read more »

Investing

Carlos Test Yoast Metadata

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »